Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

14/08/2023 07:05

Aug 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2023        Jun 30, 2022       Mar 31, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
                                    (-100.0 pct)                     
  Operating     loss 275 mln        loss 304 mln        loss 1.31    
  Recurring     loss 280 mln        loss 307 mln        loss 1.32    
  Net           loss 280 mln        loss 308 mln        loss 1.32    
  EPS          loss 43.07 yen      loss 56.96 yen    loss 207.71 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T